NCT00677079View on ClinicalTrials.gov

Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Primary Peritoneal CancerAdvanced Epithelial Ovarian Cancer
Interventions
DRUG

Iniparib

"Body weight adjusted dose~1 hour intravenous infusion"

Trial Locations (1)

10021

New York

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY